There are currently 168 active clinical trials seeking participants for Lung Cancer research studies. The states with the highest number of trials for Autism participants are Ohio, California, Illinois and Michigan.
Detection of Genetic Markers of Lung Cancer
NCT00280202
Recruiting
The purpose of this research study is to determine the genetic changes and immunologic changes that are involved in the development and progression of bronchogenic lung cancer.
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
03/08/2023
Locations: Hillman Cancer Center, Pittsburgh, Pennsylvania
Conditions: Lung Cancer
Register for Updates
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
NCT05068232
Recruiting
This this study is for individuals who have treatment-naïve extensive-stage small cell lung cancer (small cell lung cancer that wont respond to treatment). Doctors leading this study hope to learn if combining durvalumab, carboplatin and etoposide with hyofractionated ablative radiation therapy (radiation focused on certain parts of the body) will help treat your cancer and improve how long you can live with extensive-stage small cell cancer without it getting worse (progression-free survival).... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
02/14/2023
Locations: University of Chicago Medicine, Chicago, Illinois
Conditions: Small-cell Lung Cancer, Extensive-stage Small-cell Lung Cancer, Lung Cancer
Register for Updates
Image Guided VATS vs. VATS Resection
NCT03623958
Recruiting
To evaluate workflow and outcomes of iVATS and standard VATS for small pulmonary nodules. The outcomes of the patients will be evaluated separately as there will be no direct comparison of the two arms.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/06/2023
Locations: Brigham and Women's Hospital, Boston, Massachusetts
Conditions: Lung Cancer
Register for Updates
The Transitions Project: Efficacy Trial
NCT05087251
Recruiting
The aim of this study is to evaluate the efficacy of a brief psychoeducational intervention to improve quality of life in patients with lung cancer who are transitioning from active treatment to surveillance.
Gender:
All
Ages:
21 years and above
Trial Updated:
11/09/2022
Locations: Massachusetts General Hospital Cancer Center, Boston, Massachusetts +1 locations
Conditions: Lung Cancer
Register for Updates
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT04678648
Recruiting
RSC-101 is a Phase 1a/1b clinical trial of RSC-1255 in adult study participants with advanced solid tumor malignancies who are intolerant of existing therapies known to provide clinical benefit, have disease that has progressed after standard therapy, or have previously failed other therapies. The study has two phases. The purpose of Phase 1a (Dose Escalation) is to confirm the appropriate treatment dose and Phase 1b (Dose Expansion) is to characterize the safety and efficacy of RSC-1255.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/24/2022
Locations: University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles, California +5 locations
Conditions: Advanced Malignant Solid Neoplasm, RAS Mutation, Lung Cancer, Colon Cancer, Glioblastoma, Pancreatic Cancer
Register for Updates
Pilot Study of Biopsy Scanner for Evaluation of Bronchoscopic Small Biopsy Specimens to Determine Adequacy
NCT05393154
Recruiting
The aim of the study is to assess the performance of Aquyre Biopsy Scanner technology (the FDA class I medical device) at determining if tissue from the lymph nodes and lung nodules, taken during a bronchoscopy procedure, is adequate for a diagnosis. The study will assess how well the Aquyre Biopsy Scanner can differentiate between tissue samples that meet certain requirements that allow for further diagnostic analysis and samples that do not.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/24/2022
Locations: Boston Medical Center, Boston, Massachusetts
Conditions: Lung Cancer
Register for Updates
DNA Analysis of Blood and Tissue From Patients With Lung Cancer
NCT00471978
Recruiting
RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help the study of cancer in the future. PURPOSE: This clinical trial is analyzing the DNA in blood and tissue samples from patients with lung cancer.
Gender:
All
Ages:
Between 18 years and 120 years
Trial Updated:
04/14/2022
Locations: Massachusetts General Hospital, Boston, Massachusetts +1 locations
Conditions: Lung Cancer
Register for Updates
Molecular and Genetic Analysis of Lung Cancer
NCT03029325
Recruiting
Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/14/2022
Locations: Massachusetts General Hospital, Boston, Massachusetts
Conditions: Lung Cancer
Register for Updates
Idylla EGFR Lung Trial
NCT04962191
Recruiting
This retrospective, observational study will compare the results of a BioCartis' EGFR mutation test on the Idylla platform with test results from SoC pathology results from tissue biopsies in the same setting. A comparable rapid testing platform for EGFR may serve as a more accessible means to diagnose, and overall, more patients treated successfully with targeted therapies. Up to 150 samples will be tested and compared with existing results.
Gender:
All
Ages:
18 years and above
Trial Updated:
07/12/2021
Locations: 6555 Sanger Rd, Suite 260, Orlando, Florida
Conditions: Lung Cancer, Technology, Oncology
Register for Updates
Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer
NCT03891615
Recruiting
This research study is studying a combination of drugs as a possible treatment for EGFR-Mutated Advanced Lung Cancer. The names of the study drugs involved in this study are Niraparib and Osimertinib.
Gender:
All
Ages:
18 years and above
Trial Updated:
12/14/2020
Locations: Dana Farber Cancer Institute, Boston, Massachusetts +2 locations
Conditions: Lung Cancer
Register for Updates
4D-MRI for Precision Medicine
NCT04657042
Recruiting
The purpose of this study is to develop new ways to make medical images of the lungs and liver of adults using a technique called four-dimensional magnetic resonance imaging (4D-MRI). This technique produces three-dimensional movies of the inside of the chest and abdomen while the patient is breathing. (The fourth dimension is time!) This new way of medical imaging is being developed to help cancer patients undergoing radiation therapy. Radiation therapy is used to treat cancerous tumors. For r... Read More
Gender:
All
Ages:
Between 18 years and 82 years
Trial Updated:
12/07/2020
Locations: University of Virginia, Charlottesville, Virginia
Conditions: Healthy Volunteers, Liver Cancer, Lung Cancer
Register for Updates
Photodynamic Therapy (PDT) Oncology Registry
NCT01842555
Recruiting
The data elements for the PDT Registry project include virtually all the elements in the standard hospital-based cancer registry record, although in some cases at a finer level of detail. All data points should be found in the participant's medical record. The principal difference between the PDT Registry data set and that collected by the registries is the inclusion of more information specific to PDT.
Gender:
All
Ages:
18 years and above
Trial Updated:
08/23/2018
Locations: Main Line Health, Lankenau Medical Center, Wynnewood, Pennsylvania
Conditions: Lung Cancer, Esophageal
Register for Updates